JOHNSON KENNETH ERLAND (See Remarks) purchased 65.0% of their position (2.41K shares) of XERIS PHARMACEUTICALS INC on the open market
Open‑market purchase worth $10.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/18/2020ACC: 0000899243-20-004907
Officer· See Remarks
Since Jan 2019
+2.41K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.41K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.41K
Price / share
$4.15
Trade value
$10K
% of position
65.0%
2/14/2020
3.71K→6.12K
Total
Net shares
+2.41K
Net value
$10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/14/2020 | P · Purchase | +2.41K | $4.15 | $10K | 65.0% | 3.71K | 6.12K |
| Total | +2.41K | $10K | ||||||
Derivative Transactions0
No derivative transactions reported